drugset / Trial / NCT03825315
DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a randomized, double-blind, placebo-controlled, parallel group, multi-center trial of a single administration of DaxibotulinumtoxinA (DAXI) (high-dose; low-dose) for injection versus placebo for the management of Plantar Fasciitis.
Timeline
- Start
- 2018-12-31
- Primary completion
- 2020-06-04
- Completion
- 2020-06-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 80 iu | — |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 120 iu | — |